Services of MTRC

MTRC continues releasing new seminars on the topics on market access. The seminar discusses key stakeholders, money flow, reimbursement in hospital and ambulatory settings, Nomenclature of medical services, specifics of reimbursement processes and the role of HTA.

MTRC continues releasing new seminars on the topics on market access. The seminar discusses key stakeholders, money flow, reimbursement in hospital and ambulatory settings, role of DRG and fee for service model, specifics of reimbursement processes and the role of HTA.

MTRC continues releasing new seminars on the topics on market access. This time the seminar covers a very complex market, Turkey. The seminar discusses key stakeholders, money flow, specifics of financing of public and university hospitals, reimbursement in hospital and ambulatory settings, innovation funding, details of the reimbursement application process and the role of health technology assessment.

Responding to requests from our clients, we are starting to provide the services of development of value dossiers. We can support our clients with both early and core value dossiers. Dossiers can be developed from the global or European perspectives.

In response to multiple requests from our clients, we have started the provision of service of health economic modeling for medical technologies and IVD tests in Europe. Both early and comprehensive models eligible for publication are supported.

We have released the second part of the interview on the Market Access Insider channel on Youtube. The interview covered key stakeholders, procedure coding, principles of functioning of DRG system and add-on reimbursement for medical devices via LPPR List. Reimbursement pathways for devices, evidence requirements, pricing considerations, innovation funding (PHRC, PRME, forfeit innovation, Article 51, ETAPES program) were also discussed.

Using its deep knowledge of market access pathways in Europe and a specific, fact-based, benchmarking approach, MTRC can support the development of reliable clinical and economic evidence generation strategy.

Using its deep expertise in payment systems in Europe, MTRC has started provision of service of cost analysis to inform the development of health economic models and adaptation of existing models to settings of 19 European countries.

MTRC is expanding its service offering to pharma companies. The scope of the services includes reimbursement analysis and strategy for hospital (high cost) drugs, cell and gene therapies, companion diagnostics, drug delivery systems and e-health solutions.

The seminar includes overview of topics of reimbursement, funding, payment mechanisms for IVD tests in hospital, day case and out-patient settings, health technology assessment, innovation funding, role of clinical and economic evidence, stakeholder engagement. Data from 10 EU countries are used. The seminar is available as a pre-recorded on-demand webinar or full presentation in Acrobat PDF.

Technical overviews include details of application processes for procedure codes and payments (e.g. DRG), inclusion into health benefit catalogs. Overviews are available as presentations in Acrobat PDF.

Educational modules include an overview of key stakeholders, money flow, payment model for IVD tests in the ambulatory sector, the process of creation of reimbursement for novel IVD tests. Overviews are available for France, Germany, Italy, Switzerland. Overviews are available as presentations in Acrobat PDF.